Feed/Companies/Pulnovo Medical

Pulnovo Medical

As of 14 Oct 2026, Pulnovo Medical has raised $100M across 1 verified round on record; latest: $100 million funding round led by Medtronic, announced 19 Apr 2026.

BUILT ON

Visit site

Pulnovomed develops and conducts clinical trials for innovative treatments in pulmonary hypertension and heart failure, specifically focusing on pulmonary artery denervation technology.

pulnovomed.comLinkedInMedtech

LATEST ROUND

Funding round

$100M · 2026-04-19

RAISED ON RECORD · USD

$100M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 1 publisher

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Funding round

$100M · 2026-04-19

[ HISTORY ]

led by Medtronic

Round	Amount	Announced	Lead	Buzz
Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$100M	2026-04-19	Medtronic	No recent discussion
1 source [ VERIFIED · CORRECTED ] read against 1 source Date 2026-04-21 → 2026-04-19 · medtechdive.com The source describes the financing as an investment/financing round but does not state a conventional stage. The Sunday disclosure date is resolved from the article's April 21, 2026 publication date. Published by hand (medtechdive.com): "Medtronic has led a $100 million investment in Pulnovo Medical to support development and commercialization of a denervation device to treat a form of high blood pressure.": biggest-rounds completeness (K): the round's own page (company, lead investor or trade press) states it

Pulnovo Medical

Company

Rounds

Sources

Profile

Investors

Pulnovo Medical

Rounds

Profile

Sources

Funding round$100M2026-04-191 source

Investors

Funding round$100M2026-04-191 investor